| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
List Alan serves as a Chief Medical Officer at DTIL. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $46K at current prices.
Historically, List Alan's trades have earned a strong insider score of 81/100 across 6 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +56.1%.
The biggest single holding is DTIL (~$46K) as Chief Medical Officer. The recent filings there lean toward selling, a net 47,073 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | DTIL Precision Biosciences Inc | Chief Medical Officer | Sale+OE | 290 | $10.32 | $2,992.80 | -6.1% | -12.1% | -47.0% | |
| Apr 30, 2024 | DTIL Precision Biosciences Inc | Chief Medical Officer | Sale+OE | 238 | $10.03 | $2,386.43 | -5.9% | -3.9% | -45.8% | |
| Jan 22, 2024 | DTIL Precision Biosciences Inc | Chief Medical Officer | Sale+OE | 21,526 | $0.36 | $7,749.36 | -18.5% | -13.2% | -59.1% | |
| Apr 27, 2023 | DTIL Precision Biosciences Inc | Chief Medical Officer | Sale+OE | 7,771 | $0.79 | $6,139.09 | -12.1% | -28.7% | -61.9% | |
| Mar 6, 2023 | DTIL Precision Biosciences Inc | Chief Medical Officer | Sale+OE | 9,473 | $1.07 | $10,136.11 | -19.9% | -24.3% | -62.0% | |
| Apr 27, 2022 | DTIL Precision Biosciences Inc | Chief Medical Officer | Sale+OE | 7,775 | $2.10 | $16,327.50 | -29.9% | -28.2% | -60.8% |